Table 2 Incidence and duration of new kidney replacement therapy and urea levels
W | AKI patients | High protein | Usual protein | p values |
|---|---|---|---|---|
(n = 312) | (n = 163) | (n = 149) | ||
Duration of kidney replacement from randomization (among patients who received dialysis)* Median [IQR] | (107) 6.0 [3.0–10.0] | (60) 5.0 [2.0–10.0] | (47) 6.0 [4.0–10.0] | 0.21 |
New KRT after randomization | 64 (20.5%) | 34 (20.9%) | 30 (20.1%) | 0.87 |
Average Urea (all patients) (mmol/L) | 18.7 ± 9.8 | 19.7 ± 9.8 | 17.6 ± 9.7 | 0.04 |
Average urea ≥ 30 mmol/L (all patients) | 42 (13.5%) | 26 (16.0%) | 16 (10.9%) | 0.18 |